Baotou Dongbao Bio-Tech Co.,Ltd (SHE:300239)
China flag China · Delayed Price · Currency is CNY
4.700
-0.020 (-0.42%)
Jul 30, 2026, 3:04 PM CST

SHE:300239 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
458.68482.38532.1748.69356.11225.87
Cash & Short-Term Investments
458.68482.38532.1748.69356.11225.87
Cash Growth
-4.03%-9.34%-28.93%110.24%57.66%370.09%
Accounts Receivable
246.97252.85333.81302.92335.79302.47
Other Receivables
1.041.021.291.463.155.19
Receivables
248.01253.87335.1304.38338.93307.66
Inventory
415.85401.37354.46281.53317.84346.02
Other Current Assets
11.5710.8412.961511.0113.04
Total Current Assets
1,1341,1481,2351,3501,024892.59
Property, Plant & Equipment
1,2141,1951,2041,1631,019966.9
Long-Term Investments
18.519.1221.0524.4528.3234.88
Other Intangible Assets
133.93135.79143.26144.84152.14174.6
Long-Term Deferred Tax Assets
19.0218.213.0213.6511.8410.67
Long-Term Deferred Charges
3.093.262.96.444.639.46
Other Long-Term Assets
51.5329.626.1140.2468.2123.13
Total Assets
2,5742,5502,6252,7422,3082,112

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
151.87152.18216.07187.32124.79141.59
Accrued Expenses
14.1528.3728.3425.7224.3724.46
Short-Term Debt
---5.842.0750.52
Current Portion of Long-Term Debt
7.614.576.750.0441.02-
Current Income Taxes Payable
12.52.745.025.7494.45
Current Unearned Revenue
4.937.519.927.0214.294.8
Other Current Liabilities
44.6540.4857.6869.26100.73195.57
Total Current Liabilities
235.71235.85323.77300.94316.26421.39
Long-Term Debt
497.84493.7471.9462.82152-
Long-Term Unearned Revenue
50.4550.2548.5145.1648.6749.64
Long-Term Deferred Tax Liabilities
37.0836.6931.3229.925.3427.56
Other Long-Term Liabilities
101010101010
Total Liabilities
831.08826.49885.5848.82552.26508.58

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
593.61593.61593.61593.6593.6593.6
Additional Paid-In Capital
644.38644.38644.38635.82635.82635.88
Retained Earnings
535.92516.22476.46403.54299.09193.21
Treasury Stock
-56.11-56.11----
Comprehensive Income & Other
25.125.125.125.1--
Total Common Equity
1,7431,7231,7401,6581,5291,423
Minority Interest
---0.12235.13227.35180.97
Shareholders' Equity
1,7431,7231,7391,8931,7561,604
Total Liabilities & Equity
2,5742,5502,6252,7422,3082,112

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
505.45498.27478.65468.71195.0950.52
Net Cash (Debt)
-46.77-15.8853.45279.98161.02175.35
Net Cash Growth
---80.91%73.88%-8.17%-
Net Cash Per Share
-0.07-0.030.080.460.270.31
Filing Date Shares Outstanding
583.03583.03593.61593.6593.6593.6
Total Common Shares Outstanding
583.03583.03593.61593.6593.6593.6
Working Capital
898.4912.61910.861,049707.64471.21
Book Value Per Share
2.992.962.932.792.572.40
Tangible Book Value
1,6091,5871,5961,5131,3761,248
Tangible Book Value Per Share
2.762.722.692.552.322.10
Buildings
-699.98653.56550.38552.09522.11
Machinery
-907.02823.47647.13640.8612.12
Construction In Progress
-150.86204.96364.94160.2994.1